DAVID PERNOCK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EAGLE PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2016-07-12 The following table sets forth in summary form information concerning the compensation that we paid or awarded during the fiscal year ended December 31, 2015, and during the three-month transition period ended December 31, 2014, to each of our non-employee directors: David Pernock 2015 24,375 325,171 349,546

Data sourced from SEC filings. Last updated: 2025-10-12